iShares US Medical Devices

Most Recent

  • uploads///eps
    Earnings Report

    What to Expect from St. Jude Medical’s Earnings in 2Q16

    In 1Q16, St. Jude Medical exceeded analysts’ EPS (earnings per share) estimate of $0.89 as well as the revenue estimate of ~$1.4 billion.

    By Sarah Collins
  • Healthcare

    Must-know: Current medical devices risks and opportunities

    The industry looks to be weathering the Obamacare storm, yet there are still a couple key reasons to be wary of the industry over the coming months.

    By Amritpal Khalsa
  • Healthcare

    Why medical device companies’ federal contracts will boost stocks

    A group of medical device manufacturers was recently awarded a slew of government contracts for devices, equipment, and supplies.

    By Amritpal Khalsa
  • uploads///analyst recommendations
    Company & Industry Overviews

    Most Analysts Rate Boston Scientific a ‘Buy’

    Based on the recommendations of 27 brokerage firms in a Bloomberg survey, about 78% gave Boston Scientific a consensus rating of “buy.”

    By Sarah Collins
  • uploads///oncology
    Company & Industry Overviews

    Varian Medical Systems’ Oncology Devices Are Key to Sales Growth

    Varian Medical Systems commands the majority share of the oncology device market in the United States.

    By Sarah Collins
  • uploads///analyst recommendations
    Earnings Report

    Analysts Recommend Boston Scientific as a Strong ‘Buy’

    Boston Scientific will release its 1Q16 earnings results on April 27. In a survey of 28 brokerage firms, about 78.6% of the firms rated Boston Scientific as a “buy.”

    By Sarah Collins
  • uploads///R Medical Peers
    Company & Industry Overviews

    Is ROP’s Medical Device Segment the Biggest in Healthcare?

    Going forward, both research and development and sales and supply chain strategies will play crucial roles for Roper Technologies (ROP) and its peers.

    By Jessica Stephans
  • uploads///kyle sterk  unsplash
    Company & Industry Overviews

    ALGN Stock Surpasses the S&P 500 Index’s Year-to-Date Gain

    On September 28, Align Technology (ALGN) posted an ~74% increase year-to-date. In the same period, the S&P 500 Index has returned ~9%.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Zimmer Biomet Stock Regains Momentum: What’s Driving Growth?

    Ximmer Biomet (ZBH) has risen 2.1% since its 1Q17 earnings release on April 27, 2017. The results exceeded analysts’ estimates, but ZBH lowered its 2017 guidance.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Abbott Laboratories Traded at a 52-Week High after Posting Strong 4Q17 Results

    On January 29, 2018, Abbott Laboratories (ABT) closed trading at $63.31 per share. The company reported its 52-week high of $64.60 on January 25.

    By Sarah Collins
  • uploads///recommendations
    Company & Industry Overviews

    Analysts’ Latest Recommendations for Baxter: Mostly ‘Holds’

    Let’s look at Wall Street analysts’ recommendations and target prices for Baxter International (BAX) over the next 12 months.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    ABT’s Recent Stock Slump: What’s behind the Decline?

    On May 2, Abbott Laboratories (ABT) ended trading at a closing price of $58.14 per share.

    By Sarah Collins
  • uploads///core strategies
    Company & Industry Overviews

    How Are Stryker’s Core Strategies Working Toward Its Growth?

    Stryker (SYK) registered strong 3Q16 earnings on October 27, 2016. The company’s reported earnings exceeded analysts’ estimates.

    By Sarah Collins
  • uploads///heart care _
    Earnings Report

    BSX Stock Up on Strong Q2 2018 Results, Beats Estimates

    Boston Scientific (BSX) announced its Q2 earnings on July 25. BSX reported sales of $2.49 billion, up ~10.3% year-over-year.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    BD’s Stock Price Performance after Recent 52-Week High

    On December 28, Becton, Dickinson and Company (BDX), or BD, closed trading on the day at $214.32 per share. Currently, BD stock’s 50-day moving average stands at $221.22.

    By Sarah Collins
  • uploads///progress _
    Company & Industry Overviews

    Discussing Boston Scientific’s Stock Performance in 2018 So Far

    On July 9, Boston Scientific (BSX) stock ended the trading day at $33.79, a rise of ~0.50% compared to the previous day.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Abbott Laboratories’ Stock Performance after a Recent Bull Run

    On February 16, Abbott Laboratories (ABT) closed trading at $60.17 per share.

    By Sarah Collins
  • uploads///stock performance
    Earnings Report

    Abbott Laboratories’ Stock Price Performance in July

    Year-to-date, ABT stock has risen 12.8%. Over the last month, the stock has returned ~4.0%.

    By Sarah Collins
  • uploads///highlights
    Company & Industry Overviews

    Can BAX Stock Maintain Momentum after Recent Highs?

    BAX stock plummeted in late 2016 but has witnessed a rise in recent months, trading at a 52-week high on October 27, 2017.

    By Sarah Collins
  • uploads///ONCOLOGY GROWTH DRIVERS
    Company & Industry Overviews

    Eclipse System Expands Varian’s Market Presence in Australia

    On December 12, Varian announced that the Peter MacCallum Cancer Centre in Melbourne had selected its Eclipse treatment planning system for the replacement of its existing platform.

    By Sarah Collins
  • uploads///VALUATION
    Company & Industry Overviews

    How Edwards Lifesciences Trades Compared to Its Peers

    As of August 30, 2016, Edwards Lifesciences (EW) was trading at a forward PE (price-to-earnings) multiple of 40x.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    How Has Boston Scientific Stock Performed Recently?

    Boston Scientific (BSX) was trading at $27.9 on June 29, 2017.

    By Sarah Collins
  • uploads///hand __
    Company & Industry Overviews

    BSX Stock Regains Momentum after Its Recent Bearish Trend

    On February 14, 2018, Boston Scientific stock closed the day at $26.81. The stock was trading near its 50-day moving average of $26.82.

    By Sarah Collins
  • uploads///STOCK PRICE
    Earnings Report

    ZBH Stock Price Momentum Likely to Trend Upward

    On January 24, Zimmer Biomet Holdings (ZBH) closed trading at a share price of $125.02. The company traded at a 52-week high of $133.49 on July 17, 2017.

    By Sarah Collins
  • uploads///revenue estimates
    Company & Industry Overviews

    Stryker’s Recent Stock Price Movement: Upside Potential?

    Stryker stock has registered slightly volatile activity in the past few months. However, the stock largely remains on a bullish trajectory.

    By Sarah Collins
  • uploads///STOCK PRICE
    Earnings Report

    A Look at Medtronic’s Recent Stock Performance

    Medtronic (MDT) was trading at $83.9 on May 22, 2017. It had a 50-day moving average of $82.1 and a 200-day moving average of $78.4.

    By Sarah Collins
  • uploads///COMPLEMENTARY PORTFOLIO
    Company & Industry Overviews

    Effect of Claris Injectables Acquisition on Baxter’s 2017 Growth

    On July 27, 2017, Baxter International (BAX) completed the acquisition of Claris Injectables, which is expected to help expand and strengthen Baxter’s core capabilities.

    By Sarah Collins
  • Healthcare

    Must-know: Key export barriers for medical device manufacturers

    Most large U.S. manufacturers have invested significant capital into emerging markets, including Medtronics, Johnson & Johnson, GE, and Stryker.

    By Amritpal Khalsa
  • uploads///stock price
    Company & Industry Overviews

    How Has Thermo Fisher Scientific’s Stock Performed Recently?

    Thermo Fisher Scientific (TMO) was trading at $140.3 on November 28, 2016.

    By Sarah Collins
  • uploads///Part  Graph
    Company & Industry Overviews

    Waters Introduces Symphony, Its New Data Pipeline Software

    A top IHI performer on June 2, 2016, was Waters (WAT), which rose 0.9%. The company was in the news with the introduction of its new data pipeline software.

    By Peter Neil
  • uploads///stock price
    Company & Industry Overviews

    How Has Varian Medical Systems Stock Been Performing Recently?

    On December 22, Varian Medical Systems closed the trading day at a price of $110.9. The stock closed 0.18% higher on the day compared to the previous day’s close.

    By Sarah Collins
  • uploads///ste ps
    Earnings Report

    How Did STERIS Perform in a Competitive Market?

    The PE ratios of STERIS, Stryker Corporation, Ecolab, Hill-Rom Holdings, and Cantel Medical are 33.46x, 31.05x, 29.64x, 37.37x, and 51.55x, respectively.

    By Gabriel Kane
  • uploads///Diabetes
    Company & Industry Overviews

    What to Expect from Medtronic’s Diabetes Segment

    In September 2018, Medtronic (MDT) announced that the company would acquire all outstanding shares of Mazor Robotics (MZOR) for $58.50 per American depository share.

    By Daniel Collins
  • Healthcare

    St. Jude Medical: Key strategic stock outlook

    Laser focus CEO Dan Starks told an audience last week that excessive focus on emerging markets “fails to appreciate the potential of the medical device industry.” The CEO firmly believes that straying into emerging markets implies a lack of imagination and focus. This is highly controversial, as most medical technology giants have been investing significantly […]

    By Amritpal Khalsa
  • uploads///Graph Part  Dec
    Company & Industry Overviews

    Anacor Stayed Positive among the Hammered Mid-Caps

    Anacor Pharmaceuticals (ANAC) was one of the top mid-cap performers for the week. It rose by 5.9% for the week. The stock rose due to good trading volumes.

    By Peter Neil
  • uploads///Part  Graph
    Company & Industry Overviews

    A Closer Look at IHI’s Mid-Cap Performances

    Varian Medical Systems (VAR) rose by 0.4% on May 12, 2016. Varian has a weight of ~1.8% in IHI’s portfolio.

    By Peter Neil
  • uploads///revenues by segment
    Earnings Report

    Assessing Abbott’s 3Q17 Expectations by Segment

    In 3Q17, the Established Pharmaceuticals segment of Abbott Laboratories is expected to report high double-digit operational sales growth.

    By Sarah Collins
  • uploads///abmd
    Company & Industry Overviews

    Wall Street Analysts Are Mostly Positive on Abiomed

    On November 26, Abiomed (ABMD) stock closed at $311.15, a ~3.92% rise from its previous day’s close of $299.41 on November 23.

    By Daniel Collins
  • uploads///microbiology _
    Company & Industry Overviews

    Illumina Stock Continues Its Bull Run

    Illumina (ILMN) reached a 52-week high of $357.93 per share on August 31.

    By Sarah Collins
  • Industrials

    Brazil’s medical device industry: Health coverage outlook

    The upward trends of the healthcare market show that Brazil is positive for the medical device industry, suggesting rapid increases in demand as more and more people can afford the devices and pay accordingly.

    By Amritpal Khalsa
  • uploads///eps estimates
    Earnings Report

    What Can We Expect for Stryker’s Earnings in 2Q16?

    In 1Q16, Stryker exceeded analysts’ EPS (earnings per share) estimate of $1.20, as well as the revenue estimate of ~$2.5 billion.

    By Sarah Collins
  • uploads///Sharpe Ratio Example
    Financials

    Sharpe ratio shows healthcare ETFs are a strong relative investment

    Adjusting performance on a risk basis As new insurees flood the insurance market and baby boomers approach retirement, the healthcare space should expect dramatic increases in demand. Alongside an increase in demand, however, has been a tightening of reimbursement policy and a more stringent regulatory environment. These variables present unique risks and opportunities for healthcare […]

    By Amritpal Khalsa
  • uploads///stock trading monitor desk
    Company & Industry Overviews

    What’s Driving TransEnterix Stock on January 8?

    On January 8, TransEnterix (TRXC) rose 11.15% compared to its previous closing price and reached $2.99 in its pre-market trading session.

    By Margaret Patrick
  • uploads///MDT net income
    Company & Industry Overviews

    A Look at Medtronic’s Earnings Trends and Guidance for Fiscal 2019

    Medtronic (MDT) reported net income of $1.1 billion in the second quarter of fiscal 2019 compared to $2.0 billion in the second quarter of fiscal 2018.

    By Daniel Collins
  • uploads///RTG
    Company & Industry Overviews

    How Does Medtronic’s Restorative Therapies & Diabetes Group Look?

    Medtronic’s Restorative Therapies Group consists of Spine, Brain, Specialty and Pain therapies.

    By Daniel Collins
  • uploads///BSX
    Company & Industry Overviews

    Why Analysts Are Mostly Positive on Boston Scientific Stock

    Boston Scientific stock rose from $24.79 at the close of market on December 29, 2017, to $34.80 at the close of market on November 23.

    By Daniel Collins
  • uploads///ISRG
    Company & Industry Overviews

    Intuitive Surgical Stock Has Seen Growth of 34% Year-to-Date

    Intuitive Surgical’s stock price rose from $364.94 at the close of market on December 29, 2017, to $489.57 on November 23, 2018.

    By Daniel Collins
  • uploads///Chart  Healthcare Revenues
    Company & Industry Overviews

    Inside General Electric’s Healthcare Business Unit Spin-Off Plan

    As part of its major restructuring plan, General Electric (GE) intends to spin off its Healthcare segment and turn it into a standalone entity.

    By Anirudha Bhagat
  • uploads///lab _
    Earnings Report

    Thermo Fisher Beats Analysts’ Estimates in Q3 2018 Earnings

    Thermo Fisher Scientific (TMO) reported its third-quarter results today. It surpassed analysts’ estimates for EPS and revenue.

    By Mike Benson
  • uploads///Chart
    Earnings Report

    Thermo Fisher’s Third-Quarter Revenue Estimates

    The Life Sciences Solutions segment, including reagents, instruments, and consumables, contributes ~25% of Thermo Fisher’s total revenues.

    By Mike Benson
  • uploads///hospital _
    Earnings Report

    Zimmer Biomet Holdings: Revenue Trends ahead of Its Q3 Earnings

    Zimmer Biomet (ZBH) plans to release its Q3 earnings on October 26. Analysts expect ZBH to generate third-quarter revenues of $1.8 billion.

    By Daniel Collins
  • uploads///COMPARISON
    Company & Industry Overviews

    EW Stock Returned More than the S&P 500’s Gain in 2018

    As of September 28, Edwards Lifesciences (EW) has registered a rise of ~52.5% YTD (year-to-date). In the same period, the S&P 500 has risen ~9.2%.

    By Sarah Collins
  • uploads///COMPARISON
    Company & Industry Overviews

    ABT Returns Almost Double the S&P 500’s Year-to-Date Gain

    As of September 19, Abbott Laboratories (ABT) has registered a rise of ~17% YTD (year-to-date).

    By Sarah Collins
  • uploads///chemist _
    Company & Industry Overviews

    How Thermo Fisher Scientific’s Valuation Looks in September

    Thermo Fisher Scientific currently trades at a forward PE multiple of ~19.9x.

    By Mike Benson
  • uploads///microscope _
    Company & Industry Overviews

    Medical Device ETFs: Much Higher YTD Returns in 2018

    The iShares U.S. Medical Devices ETF (IHI) and the SPDR S&P Health Care Equipment ETF have returned 26.8% and $37%, respectively, YTD.

    By Margaret Patrick
  • uploads///Chart
    Company & Industry Overviews

    What Analysts Expect for Abiomed

    Wall Street analysts estimate Abiomed (ABMD) will report 29.9% growth in revenues to ~$771.0 million in 2019 as compared to $593.7 million in 2018.

    By Mike Benson
  • uploads///STOCK PRICE
    Company & Industry Overviews

    What’s Driving Boston Scientific Stock Upward

    On April 3, 2018, Boston Scientific stock closed at $27.46, up ~2.3% from the previous day.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    How TMO Stock Has Performed Recently

    On March 14, 2018, Thermo Fisher Scientific (TMO) closed at $213.46 per share.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Reading Dentsply Sirona’s Recent Stock Performance

    On March 13, 2018, Dentsply Sirona closed trading at a price of $57.80 per share. The stock registered its 52-week high of $68.98 on November 28, 2017.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    BSX Stock Rises More Than 2% Following EMcision Acquisition

    Boston Scientific’s recent stock performance On March 6, 2018, Boston Scientific (BSX) stock closed at $27.41, higher than its 50-day moving average of $27.15 and lower than its 200-day moving average of $27.52. As of March 7, 2018, Boston Scientific’s 52-week high was $29.93 on October 23, 2017, and its 52-week low was $24.02 on March 22, 2017. Factors […]

    By Sarah Collins
  • uploads///medtech growth comparison
    Company & Industry Overviews

    Where Is SYK Stock Headed after Its Recent All-Time Highs?

    On February 26, 2018, Stryker (SYK) closed trading at $165.77. The stock was trading at its all-time high of $170 on January 29, 2018.

    By Sarah Collins
  • uploads///recommendations
    Earnings Report

    What Analysts Recommend for Medtronic ahead of 3Q18 Earnings

    Medtronic (MDT) plans to release its 3Q18 earnings results on February 20, 2018.

    By Sarah Collins
  • uploads///conclusion of the contract __
    Company & Industry Overviews

    How BD Stock Has Performed in the Last Year

    On February 6, 2018, BD released its 1Q18 earnings results, which came in ahead of expectations.

    By Sarah Collins
  • uploads///ambulance _
    Earnings Report

    BD Medical Segment Posted Strong Fiscal 1Q18 Performance

    In fiscal 1Q18, BDX’s Medication and Procedural Solutions business registered sales growth of 5.0%.

    By Sarah Collins
  • uploads///DEAL RATIONALE
    Company & Industry Overviews

    Rationale behind Varian Medical’s Acquisition of Sirtex Medical

    On January 30, 2018, Varian Medical Systems (VAR) announced that it had entered into an agreement to acquire Sirtex Medical Limited for $1.3 billion.

    By Sarah Collins
  • uploads///STOCK PRICE
    Earnings Report

    ABT Stock Trading Near Its All-Time High: What’s Driving Growth?

    Abbott Laboratories (ABT) is currently trading near its all-time high of $59.60 per share, which was reported on January 4, 2018.

    By Sarah Collins
  • uploads///valuation
    Company & Industry Overviews

    Stryker’s Latest Valuation Metrics

    As of January 9, Stryker International (SYK) was trading at a PE ratio of 34.3x and 12-month forward PE (price-to-earnings) ratio of 22.4x. So the company’s earnings are expected to grow over the next year.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Stryker’s Stock Rally Continues with 52-Week High Yesterday

    On January 9, Stryker (SYK) traded at a 52-week high of $164.2 per share. The stock ended trading with a closing price of $160.4.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Discussing Baxter International’s Recent Stock Price Highs

    On January 4, 2018, Baxter International was trading at a 52-week high of $68.86 per share, ending the day at $68.41 per share.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    A Look at Thermo Fisher Scientific’s Recent Stock Price Performance

    TMO stock reported its 52-week high of $201.20 on October 26, 2017, when the company released its 3Q17 earnings results.

    By Sarah Collins
  • uploads///product segments
    Company & Industry Overviews

    TMO’s Acquisition from EPTEK Technology Could Boost Its China Opportunity

    On December 4, 2017, Thermo Fisher Scientific (TMO) completed the acquisition of some assets from EPTEK Technology and related entities that have offices in mainland China and Taiwan.

    By Sarah Collins
  • uploads///valuation multiples
    Company & Industry Overviews

    Boston Scientific’s Latest Valuation Metrics

    As of December 19, 2017, Boston Scientific (BSX) was trading at a 12-month forward PE (price-to-earnings) ratio of 18.4x.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Boston Scientific Stock: Triggered by Recent Developments

    Boston Scientific (BSX) stock closed at $25.80 on December 18, 2017. It was trading lower than its 50-day moving average of $27.10 as well as its 200-day moving average of $27.80.

    By Sarah Collins
  • uploads///GOP TAX BILL
    Healthcare

    How the Corporate Tax Rate Cut Could Affect R&D in the Medtech Industry

    The repeal of the tax deduction for high medical expenses may reduce the number of taxpayers opting for costly medical technologies and services.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Medtronic’s Recent Stock Price Performance

    On June 26, 2017, Medtronic reported its 52-week high of $89.70, while the company’s 52-week low stood at $69.30 on January 3, 2017.

    By Sarah Collins
  • uploads///HALCYON
    Company & Industry Overviews

    Varian’s Halcyon System Sees Strong Global Growth Momentum

    Varian Medical Systems (VAR) received FDA (U.S. Food & Drug Administration) approval in June 2017 for its Halcyon system.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Understanding BD’s Recent Stock Performance

    BD has a 50-day moving average of $197.25, while its 200-day moving average is $192.35.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    How Has ZBH Stock Performed Recently?

    Zimmer Biomet Holdings (ZBH) has fallen around 0.8% over the last one week.

    By Sarah Collins
  • uploads///EPS ESTIMATES
    Company & Industry Overviews

    Inside Baxter International’s Stock Price Performance

    On September 7, 2017, BAX stock closed at $62.84 per share. It has a 50-day moving average of $61.15 and a 200-day moving average of $57.14.

    By Sarah Collins
  • uploads///revenue guidance
    Company & Industry Overviews

    Edwards Lifesciences Near 52-Week High: Can It Sustain Momentum?

    Edwards Lifesciences (EW), a leader in the artificial heart valve market, has been expanding rapidly amid its new product launches and innovative product pipeline.

    By Sarah Collins
  • uploads///CATEGORY LEADERSHIP
    Company & Industry Overviews

    Boston Scientific Is Accelerating Category Leadership Strategy

    Boston Scientific (BSX) currently has a global market opportunity of $40.0 billion, which is expected to grow to $50.0 billion by fiscal 2020.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    What’s Behind the Recent Slump in ZBH Stock Price?

    Zimmer Biomet closed trading at price of $113.1 on August 30. The stock has a 50-day moving average of $119.95 and a 200-day moving average of $120.95.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Taking a Look at Stryker’s Recent Stock Price Performance

    On August 31, Stryker (SYK) closed trading at a closing price of $139.3. It has a 50-day moving average of $144.7 and a 200-day moving average of $137.5.

    By Sarah Collins
  • uploads///services ecoomic value
    Company & Industry Overviews

    How Medtronic Is Accelerating Its Economic Value Growth Strategy

    Medtronic’s (MDT) Hospital Solutions segment registered double-digit growth in fiscal 1Q18.

    By Sarah Collins
  • uploads///analyst recommendations
    Company & Industry Overviews

    Analysts’ Recommendations for Varian Medical Systems

    With the spin-off of its Imaging Components business, Varian Medical Systems (VAR) is now more aligned with its core capabilities. In this series, we’ll discuss the company’s dynamics after the Varex spin-off.

    By Sarah Collins
  • uploads///PERFORMANCE
    Earnings Report

    Key Highlights of Varian Medical Systems’ Fiscal 2Q17 Earnings

    On April 26, 2016, Varian Medical Systems (VAR) released its 2Q17 earnings. VAR beat consensus estimates for revenues in 2Q17 by ~0.8% and reported in-line earnings per share.

    By Sarah Collins
  • uploads///STOCK
    Earnings Report

    Key Drivers behind BDX’s Recent Stock Performance

    BDX has a 50-day moving average of $196.80 and a 200-day moving average of $185.70.

    By Sarah Collins
  • uploads///eps estimates
    Earnings Report

    What to Expect from Intuitive Surgical’s 2Q17 Earnings

    Analysts estimate that Intuitive Surgical will post 2Q17 EPS (earnings per share) of ~$4.76. In 1Q17, Intuitive Surgical exceeded analysts’ diluted EPS estimate of $4.67.

    By Sarah Collins
  • uploads///STOCK
    Company & Industry Overviews

    Behind BD’s Recent New Stock Price High

    BD (BDX) closed trading at $195.3 on July 6, 2017, ahead of its 50-day moving average of $191.3 and its 200-day moving average of $181.9.

    By Sarah Collins
  • uploads///Chart  ABT
    Miscellaneous

    A Look at Abbott Laboratories Stock for 2Q17

    Wall Street analysts estimate that Abbott Laboratories (ABT) stock has the potential to return ~6.1% over the next 12 months.

    By Mike Benson
  • uploads///stock price
    Company & Industry Overviews

    Varian Medical Systems: Analyzing Its Stock Performance

    Varian Medical Systems (VAR) was trading at $102.7 on June 29, 2017. It has a 50-day moving average of $100.4 and a 200-day moving average of $88.8.

    By Sarah Collins
  • uploads///growth drivers
    Company & Industry Overviews

    FDA Warning Letter to Zimmer Biomet Resolved, Boosts Confidence

    On June 13, 2017, Zimmer Biomet (ZBH) announced that the FDA warning letter issued in June 2015 relating to its Zhejiang manufacturing facility in China has been closed.

    By Sarah Collins
  • uploads///Graph
    Miscellaneous

    Health Sector Overview: Week of June 5–9, 2017

    In the week ending June 9, 2017, the Health Care Select Sector SPDR Fund (XLV) saw a rise of 0.13%.

    By Margaret Patrick
  • uploads///stock
    Company & Industry Overviews

    Behind Thermo Fisher’s Recent Stock Performance

    TMO stock was trading at $173.2 on May 30, 2017. The stock had a 50-day moving average of $165.9 and a 200-day moving average of $153.8 that day.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    How Zimmer Biomet Stock Has Performed Recently

    Zimmer Biomet Holdings (ZBH) was trading at $118.40 on May 30, 2017. It has a 50-day moving average of $119.70 and a 200-day moving average of $114.20.

    By Sarah Collins
  • uploads///margin
    Earnings Report

    Medtronic’s Strong 4Q17 Profits Beat Analyst Expectations

    Medtronic (MDT) reported an operating margin of 30.7% of total sales in fiscal 4Q17 on a constant currency basis.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Discussing Edwards Lifesciences’ Recent Stock Movements

    Edwards Lifesciences (EW) is a leading company in the artificial heart valve market, and it’s the largest player in the TAVR (transcatheter aortic valve replacement) market.

    By Sarah Collins
  • uploads///recommendations
    Company & Industry Overviews

    What Do Analysts Recommend for Boston Scientific?

    Let’s look at Wall Street analysts’ recommendations and target prices for Boston Scientific (BSX) over the next 12 months.

    By Sarah Collins
  • uploads///CHART
    Macroeconomic Analysis

    Trump Trade Fades amid Political Debacle: What’s the Impact?

    As part of Obamacare, a medical device tax of 2.3% has been implemented on medical device companies in the United States.

    By Sarah Collins
  • uploads///stock
    Company & Industry Overviews

    Behind Boston Scientific’s Recent Stock Performance

    Boston Scientific (BSX) was trading at $26.35 on May 4, 2017, as compared to its 50-day moving average of $24.93 and its 200-day moving average of $23.38.

    By Sarah Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.